nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—ADRBK1—blood plasma—bipolar disorder	0.0227	0.0936	CbGeAlD
Isoprenaline—MAPK1—blood plasma—bipolar disorder	0.0224	0.0922	CbGeAlD
Isoprenaline—PIK3R2—nervous system—bipolar disorder	0.0168	0.0694	CbGeAlD
Isoprenaline—PIK3R1—adrenal cortex—bipolar disorder	0.0167	0.0687	CbGeAlD
Isoprenaline—PIK3R2—cerebellum—bipolar disorder	0.0159	0.0653	CbGeAlD
Isoprenaline—PIK3R3—thyroid gland—bipolar disorder	0.0136	0.056	CbGeAlD
Isoprenaline—PIK3R2—brain—bipolar disorder	0.0129	0.053	CbGeAlD
Isoprenaline—PIK3R1—thyroid gland—bipolar disorder	0.0116	0.0478	CbGeAlD
Isoprenaline—PIK3R3—nervous system—bipolar disorder	0.0114	0.0471	CbGeAlD
Isoprenaline—PIK3R3—cerebellum—bipolar disorder	0.0108	0.0443	CbGeAlD
Isoprenaline—PIK3R1—cerebellum—bipolar disorder	0.00919	0.0379	CbGeAlD
Isoprenaline—PIK3R3—brain—bipolar disorder	0.00874	0.036	CbGeAlD
Isoprenaline—ADRBK1—thyroid gland—bipolar disorder	0.00803	0.0331	CbGeAlD
Isoprenaline—MAPK1—thyroid gland—bipolar disorder	0.00792	0.0326	CbGeAlD
Isoprenaline—PIK3R1—brain—bipolar disorder	0.00746	0.0307	CbGeAlD
Isoprenaline—ADRBK1—nervous system—bipolar disorder	0.00675	0.0278	CbGeAlD
Isoprenaline—MAPK1—nervous system—bipolar disorder	0.00666	0.0274	CbGeAlD
Isoprenaline—ADRBK1—cerebellum—bipolar disorder	0.00636	0.0262	CbGeAlD
Isoprenaline—MAPK1—cerebellum—bipolar disorder	0.00626	0.0258	CbGeAlD
Isoprenaline—ADRBK1—brain—bipolar disorder	0.00516	0.0213	CbGeAlD
Isoprenaline—MAPK1—brain—bipolar disorder	0.00509	0.021	CbGeAlD
Isoprenaline—ADRB1—nervous system—bipolar disorder	0.00283	0.0116	CbGeAlD
Isoprenaline—Methyldopa—COMT—bipolar disorder	0.00266	0.118	CrCbGaD
Isoprenaline—L-DOPA—DRD5—bipolar disorder	0.00222	0.0983	CrCbGaD
Isoprenaline—CYP1A1—thyroid gland—bipolar disorder	0.00217	0.00893	CbGeAlD
Isoprenaline—ADRB1—brain—bipolar disorder	0.00216	0.0089	CbGeAlD
Isoprenaline—Phenylephrine—MAOA—bipolar disorder	0.00206	0.0914	CrCbGaD
Isoprenaline—Dopamine—DRD5—bipolar disorder	0.00206	0.0914	CrCbGaD
Isoprenaline—CYP1A1—nervous system—bipolar disorder	0.00182	0.00751	CbGeAlD
Isoprenaline—CYP1A1—brain—bipolar disorder	0.00139	0.00574	CbGeAlD
Isoprenaline—Dopamine—COMT—bipolar disorder	0.0013	0.0577	CrCbGaD
Isoprenaline—L-DOPA—DRD4—bipolar disorder	0.00113	0.0503	CrCbGaD
Isoprenaline—Pindolol—HTR1A—bipolar disorder	0.00112	0.0498	CrCbGaD
Isoprenaline—Dopamine—DRD4—bipolar disorder	0.00105	0.0468	CrCbGaD
Isoprenaline—Dopamine—MAOA—bipolar disorder	0.000981	0.0435	CrCbGaD
Isoprenaline—L-DOPA—DRD3—bipolar disorder	0.000977	0.0434	CrCbGaD
Isoprenaline—L-DOPA—DRD1—bipolar disorder	0.000959	0.0426	CrCbGaD
Isoprenaline—Dopamine—DRD3—bipolar disorder	0.000909	0.0403	CrCbGaD
Isoprenaline—Dopamine—DRD1—bipolar disorder	0.000892	0.0396	CrCbGaD
Isoprenaline—Dopamine—SLC6A3—bipolar disorder	0.000846	0.0375	CrCbGaD
Isoprenaline—Dopamine—HTR1A—bipolar disorder	0.000741	0.0329	CrCbGaD
Isoprenaline—L-DOPA—DRD2—bipolar disorder	0.000676	0.03	CrCbGaD
Isoprenaline—Norepinephrine—DRD2—bipolar disorder	0.000676	0.03	CrCbGaD
Isoprenaline—Dopamine—SLC6A4—bipolar disorder	0.000632	0.0281	CrCbGaD
Isoprenaline—Dopamine—DRD2—bipolar disorder	0.000629	0.0279	CrCbGaD
Isoprenaline—ADRB1—GPCR downstream signaling—DRD1—bipolar disorder	8.25e-05	0.000112	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—HTR2C—bipolar disorder	8.25e-05	0.000112	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—MTHFR—bipolar disorder	8.25e-05	0.000112	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—INS—bipolar disorder	8.23e-05	0.000112	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—TAC1—bipolar disorder	8.23e-05	0.000112	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—ADCY2—bipolar disorder	8.22e-05	0.000112	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TCF7L2—bipolar disorder	8.19e-05	0.000111	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—DRD2—bipolar disorder	8.14e-05	0.000111	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—MTHFR—bipolar disorder	8.12e-05	0.000111	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—ADCY2—bipolar disorder	8.09e-05	0.00011	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—HTR2C—bipolar disorder	8.07e-05	0.00011	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—DRD1—bipolar disorder	8.07e-05	0.00011	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—NRG1—bipolar disorder	8.05e-05	0.00011	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—NRG1—bipolar disorder	8.04e-05	0.000109	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—DRD3—bipolar disorder	7.99e-05	0.000109	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—HTR2A—bipolar disorder	7.93e-05	0.000108	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—HTR1A—bipolar disorder	7.91e-05	0.000108	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—DRD5—bipolar disorder	7.86e-05	0.000107	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—POMC—bipolar disorder	7.82e-05	0.000106	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—DRD3—bipolar disorder	7.82e-05	0.000106	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TAC1—bipolar disorder	7.79e-05	0.000106	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—ADCY2—bipolar disorder	7.78e-05	0.000106	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—HTR1A—bipolar disorder	7.76e-05	0.000106	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—DRD4—bipolar disorder	7.76e-05	0.000106	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—GSK3A—bipolar disorder	7.75e-05	0.000105	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—HTR2A—bipolar disorder	7.74e-05	0.000105	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—HTR1A—bipolar disorder	7.72e-05	0.000105	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—GSK3B—bipolar disorder	7.71e-05	0.000105	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—RGS4—bipolar disorder	7.71e-05	0.000105	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—POMC—bipolar disorder	7.7e-05	0.000105	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—DRD2—bipolar disorder	7.7e-05	0.000105	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—DRD5—bipolar disorder	7.69e-05	0.000105	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—TAC1—bipolar disorder	7.64e-05	0.000104	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—HTR2C—bipolar disorder	7.64e-05	0.000104	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—DRD1—bipolar disorder	7.64e-05	0.000104	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—INS—bipolar disorder	7.61e-05	0.000104	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TAC1—bipolar disorder	7.6e-05	0.000103	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—HTR1A—bipolar disorder	7.59e-05	0.000103	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—DRD4—bipolar disorder	7.59e-05	0.000103	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—RGS4—bipolar disorder	7.54e-05	0.000103	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—NDUFV2—bipolar disorder	7.5e-05	0.000102	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—HTR2C—bipolar disorder	7.49e-05	0.000102	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—DRD1—bipolar disorder	7.49e-05	0.000102	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—NTRK1—bipolar disorder	7.48e-05	0.000102	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—TAC1—bipolar disorder	7.47e-05	0.000102	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—HTR2C—bipolar disorder	7.46e-05	0.000101	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—DRD1—bipolar disorder	7.46e-05	0.000101	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—HLA-E—bipolar disorder	7.43e-05	0.000101	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NTRK2—bipolar disorder	7.43e-05	0.000101	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—NRG1—bipolar disorder	7.42e-05	0.000101	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—SNAP25—bipolar disorder	7.42e-05	0.000101	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—DRD3—bipolar disorder	7.4e-05	0.000101	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—GSK3A—bipolar disorder	7.37e-05	0.0001	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—NTRK1—bipolar disorder	7.37e-05	0.0001	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—HTR2C—bipolar disorder	7.33e-05	9.97e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—DRD1—bipolar disorder	7.33e-05	9.97e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—ADCY2—bipolar disorder	7.3e-05	9.94e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—S100B—bipolar disorder	7.27e-05	9.89e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—AKR1C4—bipolar disorder	7.27e-05	9.89e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—HTR2A—bipolar disorder	7.26e-05	9.88e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—DRD3—bipolar disorder	7.26e-05	9.88e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NTRK2—bipolar disorder	7.25e-05	9.87e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—DRD2—bipolar disorder	7.23e-05	9.84e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—DRD3—bipolar disorder	7.22e-05	9.83e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—GSK3B—bipolar disorder	7.2e-05	9.8e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—GSK3A—bipolar disorder	7.19e-05	9.79e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—DRD4—bipolar disorder	7.18e-05	9.78e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—S100B—bipolar disorder	7.16e-05	9.74e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR ligand binding—POMC—bipolar disorder	7.15e-05	9.73e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—GSK3A—bipolar disorder	7.15e-05	9.73e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—ADCY2—bipolar disorder	7.14e-05	9.72e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—ADCY2—bipolar disorder	7.11e-05	9.67e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—DRD3—bipolar disorder	7.1e-05	9.66e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—GSK3B—bipolar disorder	7.1e-05	9.66e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—DRD2—bipolar disorder	7.07e-05	9.62e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—DRD4—bipolar disorder	7.04e-05	9.59e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—DRD4—bipolar disorder	7.01e-05	9.54e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR ligand binding—POMC—bipolar disorder	7e-05	9.52e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TRPC3—bipolar disorder	6.99e-05	9.51e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—POMC—bipolar disorder	6.98e-05	9.5e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—POMC—bipolar disorder	6.93e-05	9.43e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—COMT—bipolar disorder	6.92e-05	9.42e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—MTHFR—bipolar disorder	6.91e-05	9.4e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—INS—bipolar disorder	6.89e-05	9.38e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—DRD4—bipolar disorder	6.89e-05	9.38e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—MAOA—bipolar disorder	6.88e-05	9.36e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—GSK3B—bipolar disorder	6.81e-05	9.27e-05	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—POMC—bipolar disorder	6.81e-05	9.27e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—ADCY2—bipolar disorder	6.76e-05	9.2e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TCF7L2—bipolar disorder	6.74e-05	9.17e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—DRD2—bipolar disorder	6.69e-05	9.11e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—MTHFR—bipolar disorder	6.68e-05	9.1e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—ADM—bipolar disorder	6.67e-05	9.07e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—IL1B—bipolar disorder	6.65e-05	9.05e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—GSK3B—bipolar disorder	6.65e-05	9.05e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—ADCY2—bipolar disorder	6.63e-05	9.02e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—ADCY2—bipolar disorder	6.6e-05	8.98e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TCF7L2—bipolar disorder	6.58e-05	8.95e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—ADCY2—bipolar disorder	6.56e-05	8.93e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—DRD2—bipolar disorder	6.56e-05	8.93e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—INS—bipolar disorder	6.56e-05	8.93e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—GSK3B—bipolar disorder	6.55e-05	8.92e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—TCF7L2—bipolar disorder	6.54e-05	8.9e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—DRD2—bipolar disorder	6.53e-05	8.89e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—NR1D1—bipolar disorder	6.53e-05	8.88e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TSHB—bipolar disorder	6.5e-05	8.84e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PDE4B—bipolar disorder	6.5e-05	8.84e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TACR1—bipolar disorder	6.5e-05	8.84e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—ADCY2—bipolar disorder	6.49e-05	8.83e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—INS—bipolar disorder	6.46e-05	8.79e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—DRD2—bipolar disorder	6.42e-05	8.74e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—NRG1—bipolar disorder	6.42e-05	8.73e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—POMC—bipolar disorder	6.34e-05	8.62e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—NRG1—bipolar disorder	6.32e-05	8.6e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—NCAN—bipolar disorder	6.24e-05	8.5e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—S100B—bipolar disorder	6.19e-05	8.43e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—POMC—bipolar disorder	6.18e-05	8.42e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—SLC5A3—bipolar disorder	6.12e-05	8.32e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NTRK1—bipolar disorder	6.06e-05	8.25e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TRPC3—bipolar disorder	5.96e-05	8.1e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NTRK1—bipolar disorder	5.91e-05	8.05e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—S100B—bipolar disorder	5.89e-05	8.02e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—GSK3B—bipolar disorder	5.84e-05	7.95e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—GSK3B—bipolar disorder	5.84e-05	7.94e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TRPC3—bipolar disorder	5.83e-05	7.93e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—POMC—bipolar disorder	5.8e-05	7.89e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—HTR2A—bipolar disorder	5.78e-05	7.87e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—INS—bipolar disorder	5.76e-05	7.84e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—S100B—bipolar disorder	5.75e-05	7.82e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—HTR2A—bipolar disorder	5.7e-05	7.75e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ADM—bipolar disorder	5.68e-05	7.73e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—MTHFR—bipolar disorder	5.6e-05	7.62e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ADM—bipolar disorder	5.56e-05	7.56e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TSHB—bipolar disorder	5.54e-05	7.53e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PDE4B—bipolar disorder	5.54e-05	7.53e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TACR1—bipolar disorder	5.54e-05	7.53e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—POMC—bipolar disorder	5.52e-05	7.52e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—INS—bipolar disorder	5.49e-05	7.48e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—NRG1—bipolar disorder	5.46e-05	7.44e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PDE4B—bipolar disorder	5.42e-05	7.37e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TSHB—bipolar disorder	5.42e-05	7.37e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TACR1—bipolar disorder	5.42e-05	7.37e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—HTR2A—bipolar disorder	5.39e-05	7.34e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—GSK3B—bipolar disorder	5.39e-05	7.33e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—HTR1A—bipolar disorder	5.38e-05	7.32e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—INS—bipolar disorder	5.32e-05	7.23e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—IL1B—bipolar disorder	5.3e-05	7.22e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TAC1—bipolar disorder	5.3e-05	7.21e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—IL1B—bipolar disorder	5.22e-05	7.11e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NRG1—bipolar disorder	5.2e-05	7.07e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—HTR2C—bipolar disorder	5.19e-05	7.07e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—DRD1—bipolar disorder	5.19e-05	7.07e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NRG1—bipolar disorder	5.07e-05	6.9e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—HTR2A—bipolar disorder	5.06e-05	6.89e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NTRK2—bipolar disorder	5.05e-05	6.88e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—NRG1—bipolar disorder	5.05e-05	6.87e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—DRD3—bipolar disorder	5.03e-05	6.85e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—GSK3A—bipolar disorder	5.01e-05	6.82e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—HTR2A—bipolar disorder	4.95e-05	6.74e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—DRD4—bipolar disorder	4.88e-05	6.65e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—HTR2A—bipolar disorder	4.69e-05	6.38e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—GSK3B—bipolar disorder	4.66e-05	6.34e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—POMC—bipolar disorder	4.62e-05	6.29e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—HTR2A—bipolar disorder	4.6e-05	6.26e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—ADCY2—bipolar disorder	4.6e-05	6.26e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—INS—bipolar disorder	4.59e-05	6.25e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—GSK3B—bipolar disorder	4.59e-05	6.24e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HTR1A—bipolar disorder	4.58e-05	6.24e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TCF7L2—bipolar disorder	4.58e-05	6.23e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—HTR2A—bipolar disorder	4.57e-05	6.23e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—POMC—bipolar disorder	4.55e-05	6.19e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—DRD2—bipolar disorder	4.55e-05	6.19e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—MTHFR—bipolar disorder	4.54e-05	6.18e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—INS—bipolar disorder	4.53e-05	6.16e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TAC1—bipolar disorder	4.51e-05	6.14e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—HTR2A—bipolar disorder	4.5e-05	6.12e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HTR1A—bipolar disorder	4.48e-05	6.1e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—POMC—bipolar disorder	4.48e-05	6.09e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—INS—bipolar disorder	4.45e-05	6.06e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—DRD1—bipolar disorder	4.43e-05	6.02e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HTR2C—bipolar disorder	4.43e-05	6.02e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CLOCK—bipolar disorder	4.42e-05	6.02e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TAC1—bipolar disorder	4.41e-05	6.01e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—DRD1—bipolar disorder	4.33e-05	5.89e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HTR2C—bipolar disorder	4.33e-05	5.89e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—TPH2—bipolar disorder	4.31e-05	5.87e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—TSHB—bipolar disorder	4.31e-05	5.87e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CACNB2—bipolar disorder	4.31e-05	5.87e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—POMC—bipolar disorder	4.31e-05	5.86e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NTRK2—bipolar disorder	4.31e-05	5.86e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL1B—bipolar disorder	4.3e-05	5.85e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—DRD3—bipolar disorder	4.29e-05	5.83e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—GSK3A—bipolar disorder	4.27e-05	5.81e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—DPYD—bipolar disorder	4.24e-05	5.77e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NTRK2—bipolar disorder	4.21e-05	5.73e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—DRD3—bipolar disorder	4.19e-05	5.71e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—GSK3A—bipolar disorder	4.17e-05	5.68e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—DRD4—bipolar disorder	4.16e-05	5.66e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NTRK1—bipolar disorder	4.12e-05	5.6e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—DRD4—bipolar disorder	4.07e-05	5.54e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—POMC—bipolar disorder	4.04e-05	5.5e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—S100B—bipolar disorder	4e-05	5.45e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—GSK3B—bipolar disorder	3.97e-05	5.4e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—POMC—bipolar disorder	3.95e-05	5.38e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CACNA1C—bipolar disorder	3.94e-05	5.36e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ADCY2—bipolar disorder	3.92e-05	5.33e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TCF7L2—bipolar disorder	3.9e-05	5.31e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—DRD2—bipolar disorder	3.88e-05	5.28e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PIK3C2A—bipolar disorder	3.84e-05	5.23e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ADCY2—bipolar disorder	3.83e-05	5.21e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TCF7L2—bipolar disorder	3.82e-05	5.2e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—DRD2—bipolar disorder	3.79e-05	5.16e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	3.79e-05	5.16e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—GSK3B—bipolar disorder	3.77e-05	5.14e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—POMC—bipolar disorder	3.74e-05	5.09e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—INS—bipolar disorder	3.72e-05	5.07e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—GSK3B—bipolar disorder	3.68e-05	5.01e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—POMC—bipolar disorder	3.67e-05	5e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—GSK3B—bipolar disorder	3.66e-05	4.98e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—POMC—bipolar disorder	3.65e-05	4.97e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—INS—bipolar disorder	3.63e-05	4.94e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—INS—bipolar disorder	3.61e-05	4.92e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—POMC—bipolar disorder	3.59e-05	4.89e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NRG1—bipolar disorder	3.53e-05	4.81e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NTRK1—bipolar disorder	3.51e-05	4.78e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—SNAP25—bipolar disorder	3.45e-05	4.69e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NTRK1—bipolar disorder	3.43e-05	4.67e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—S100B—bipolar disorder	3.41e-05	4.64e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—S100B—bipolar disorder	3.34e-05	4.54e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—HTR2A—bipolar disorder	3.19e-05	4.34e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ADCY2—bipolar disorder	3.05e-05	4.15e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NRG1—bipolar disorder	3.01e-05	4.1e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NRG1—bipolar disorder	2.95e-05	4.01e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL1B—bipolar disorder	2.92e-05	3.97e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HTR2A—bipolar disorder	2.72e-05	3.7e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HTR2A—bipolar disorder	2.66e-05	3.61e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—COMT—bipolar disorder	2.61e-05	3.55e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—MAOA—bipolar disorder	2.59e-05	3.53e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—GSK3B—bipolar disorder	2.56e-05	3.49e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—POMC—bipolar disorder	2.54e-05	3.46e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—INS—bipolar disorder	2.53e-05	3.44e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—GSK3B—bipolar disorder	2.19e-05	2.98e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—POMC—bipolar disorder	2.17e-05	2.95e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—INS—bipolar disorder	2.16e-05	2.93e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—GSK3B—bipolar disorder	2.14e-05	2.91e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—POMC—bipolar disorder	2.12e-05	2.89e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—MTHFR—bipolar disorder	2.11e-05	2.87e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—INS—bipolar disorder	2.11e-05	2.87e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—POMC—bipolar disorder	1.69e-05	2.3e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—INS—bipolar disorder	1.68e-05	2.28e-05	CbGpPWpGaD
